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Mutant viruses containing deletions in DNA encapsidation genes have been 
characterized in detail for Herpes simplex type I, and to some extent for Pseudorabies 
virus, and Human cytomegalovirus.  However, similar mutants for Varicella-zoster virus 
do not exist.  It is expected that the deletion of each putative DNA encapsidation gene 
will yield a phenotype consistent with a defect in DNA cleavage and/or packaging.  
These mutant viruses will be isolated by site directed homologous recombination in 
complementing cell lines expressing the respective DNA encapsidation proteins.  
Essential to this process is the isolation of stable, DNA encapsidation protein expressing 
cell lines.  Previously, we cloned each of the encapsidation ORFs into the mammalian 
expression vector, pcDNA3.1D-V5-His-Topo.  Transient expression of each of the 
pORFs was confirmed in transiently transfected MeWo cells by performing 
immunofluorescence microscopy using a V5 monoclonal antibody that recognized an 
epitope tag at the C-terminus of each polypeptide.  Each ORF (ORF25, ORF26, ORF 
30, ORF34, ORF45/42, ORF43, and ORF54) will be used in the Invitrogen Flp-In two-
plasmid system to isolate isogenic cell lines.  Flp-In Cell Lines are designed for rapid 
generation of stable cell lines that express a protein of interest from a Flp-In expression 
vector.  The cells use targeted integration of a Flp-In expression vector to ensures high-
level expression of the gene of interest.  Co-transfection of the Flp-In Cell Lines with a 
Flp-In expression vector and the Flp recombinase vector, pOG44, results in targeted 
integration of the expression vector ensuring homogeneous levels of gene expression.  
Cell lines will be tested for (i) the presence of the ORF via PCR and (ii) expression of the 
encapsidation gene product by western blot.  Clones will be expanded and analyzed for 
protein expression with either the V5 monoclonal or pORF specific antisera. 
 
